Infliximab and Intravenous Immunoglobulin Therapy in Treating Patients With Steroid-Refractory Pneumonitis
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Jarushka Naidoo
ECOG-ACRIN Cancer Research Group
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
18 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Northwestern University
Chicago, Illinois, United States
- Johns Hopkins University/sidney Kimmel Cancer Center
Baltimore, Maryland, United States
- Bronson Battle Creek
Battle Creek, Michigan, United States
- Mercy Health Saint Mary'S
Grand Rapids, Michigan, United States
- Spectrum Health at Butterworth Campus
Grand Rapids, Michigan, United States
- West Michigan Cancer Center
Kalamazoo, Michigan, United States
- Mercy Health Mercy Campus
Muskegon, Michigan, United States
- Lakeland Hospital Niles
Niles, Michigan, United States
- Cancer and Hematology Centers of Western Michigan - Norton Shores
Norton Shores, Michigan, United States
- Spectrum Health Reed City Hospital
Reed City, Michigan, United States
- Lakeland Medical Center Saint Joseph
Saint Joseph, Michigan, United States
- Marie Yeager Cancer Center
Saint Joseph, Michigan, United States
- Munson Medical Center
Traverse City, Michigan, United States
- Metro Health Hospital
Wyoming, Michigan, United States
- Memorial Sloan Kettering Cancer Center
New York, New York, United States
- Fox Chase Cancer Center
Philadelphia, Pennsylvania, United States
- Vcu Massey Cancer Center at Stony Point
Richmond, Virginia, United States
- Virginia Commonwealth University/massey Cancer Center
Richmond, Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 7 Jan 2021
- Primary completion
- 21 Dec 2023
- Completion
- 21 Dec 2023
- Last update posted
- 6 Jul 2026
- Registered enrollment
- 1
- Registry id
- NCT04438382
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.